Diana H. Quan

Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model

Yu Lin, Diana H. Quan, Rachel Yoon Kyung Chang et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2020 · 74 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +10

Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization

Thaigarajan Parumasivam, Sharon Shui Yee Leung, Diana H. Quan et al. · European Journal of Pharmaceutical Sciences · 2016 · 55 citations

Pharmacy, Pharmaceutics, Pharmacology +14

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs

Anneliese S. Ashhurst, Manuela Flórido, Leon C. W. Lin et al. · Frontiers in Immunology · 2019 · 42 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Synthetic protein conjugate vaccines provide protection against <i>Mycobacterium tuberculosis</i> in mice

Cameron C. Hanna, Anneliese S. Ashhurst, Diana H. Quan et al. · Proceedings of the National Academy of Sciences · 2021 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

B-Type Natriuretic Peptide Inhibited Angiotensin II-Stimulated Cholesterol Biosynthesis, Cholesterol Transfer, and Steroidogenesis in Primary Human Adrenocortical Cells

Faquan Liang, Ann M. Kapoun, Andrew Lam et al. · Endocrinology · 2007 · 36 citations

Life Sciences, Endocrinology, Pharmacology +17